StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JAMESWARREN.BO$275.80-0.99%
Fair $275.80+0.0%

JAMESWARREN.BO

James Warren Tea Limited

Consumer Defensive / Farm ProductsBSE

$275.80

-2.75 (-0.99%)

Fairly Valued+0.0%Fair Value $275.80Fund rank 22/100 · Data gapFallback financials|
SA 33/D
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 15%

FCF escenarios

weak_data · normalized FCF $-4.8M · quality 30.0/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

33/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · JAMESWARREN.BOLocal privado en este navegador · James Warren Tea Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.0B

P/E

1.3x

↓

EV/EBITDA

0.9x

↓

ROE

54.0%

↑

Gross Margin

93.5%

↑

Debt/Equity

N/A

•
52-Week Range$276
$248$409

TradingView lightweight chart

JAMESWARREN.BO price, volumen y niveles de valoración

Último $275.80Periodo +85.7%
Fair value: $275.80

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+14.1%

FCF CAGR

+43.3%

FCF margin

13.9%

FCF / Net income

0.22x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.61B · net income $1.01B · FCF $223.7M

2022-FY → 2025-FY

Gross margin

93.5%+1.4% pts

Operating margin

18.0%+14.2% pts

Net margin

63.1%+55.5% pts

FCF margin

13.9%+6.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.61B$1.61B$1.13B$1.26B$1.08B
Net Income$1.01B$1.01B$18.8M$94.9M$82.5M
EBITDA$1.06B$1.06B$42.7M$128.3M$121.8M
EPS274.04274.044.7721.5615.77
Gross Margin93.5%93.5%89.1%94.0%92.1%
Operating Margin18.0%18.0%-12.9%-1.2%3.8%
Net Margin63.1%63.1%1.7%7.5%7.6%
Cash Flow
Free Cash Flow$223.7M$223.7M$-167.1M$-4.8M$76.1M
Returns
ROE54.0%54.0%2.2%9.2%8.8%
Valuation
P/E1.321.3247.2911.8315.75
EV/EBITDA0.940.9418.678.5910.03
P/B0.540.540.971.091.38
Growth & Yield
Revenue Growth41.5%41.5%-10.0%16.7%—
EPS Growth5645.1%5645.1%-77.9%36.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-55.3%

fácil

EPS terminal req.

$24.47

Spread vs growth

5700.4%

5Y implied EPS CAGR

-35.9%

fácil

EPS terminal req.

$29.61

Spread vs growth

5681.0%

10Y implied EPS CAGR

-16.0%

fácil

EPS terminal req.

$47.69

Spread vs growth

5661.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -17.9%

Total return

-17.9%

Start / end P/E

70.4x → 1.0x

EPS bridge

4.77 → 274.04

Residual

-5564.4%

EPS growth+5645.1%
Multiple rerating-98.6%
Dividend+0.0%
Residual / FX / buybacks / cross-term-5564.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.